ARCL Organics

Has ARCL Organics declared dividend?

No Dividend History Available

Is ARCL Organics overvalued or undervalued?

As of July 18, 2024, ARCL Organics is fairly valued with a PE ratio of 16.53 and an EV to EBITDA of 9.24, but despite a strong 1Y return of 361.31%, it does not qualify as a compelling investment compared to peers.

As of 18 July 2024, the valuation grade for ARCL Organics has moved from risky to does not qualify, indicating a significant change in its investment profile. The company appears to be fairly valued, with a PE ratio of 16.53, an EV to EBITDA of 9.24, and a ROCE of 19.92%. In comparison to peers, Chambal Fertilisers & Chemicals Ltd. has a more attractive PE ratio of 13.11, while Coromandel International Ltd. is deemed very expensive with a PE of 37.58.<BR><BR>Despite the recent stock performance showing a 1Y return of 361.31% compared to the Sensex's 7.53%, the current valuation metrics suggest that ARCL Organics is not undervalued. The company's ratios indicate it is positioned reasonably within its sector, but it does not present a compelling case for investment at this time.

What is the technical trend for ARCL Organics?

As of June 2, 2025, ARCL Organics shows a mildly bullish trend, supported by a bullish MACD and daily moving averages, but tempered by a mildly bearish KST and Dow Theory signals.

As of 2 June 2025, the technical trend for ARCL Organics has changed from bullish to mildly bullish. The weekly MACD remains bullish, while the daily moving averages are also bullish, indicating some positive momentum. However, the weekly KST is mildly bearish and Dow Theory suggests a mildly bearish stance on the weekly timeframe. The Bollinger Bands on the monthly chart are mildly bullish, which provides some support to the overall mildly bullish outlook. The RSI shows no signals on both weekly and monthly timeframes, indicating a lack of momentum confirmation. Overall, the current technical stance is mildly bullish, driven primarily by the bullish MACD and daily moving averages, tempered by the mildly bearish KST and Dow Theory signals.

Who are the peers of the ARCL Organics?

ARCL Organics' peers include Alufluoride, Kesar Petroprod., Hind. Organ. Chem., Sadhana Nitro, Oriental Carbon, IVP, Kanchi Karpooram, ZRZ Bioenergy, and Polychem. Notably, ARCL Organics has a 1-year return of 258.88%, significantly higher than its peers, with Kesar Petroprod. leading at 59.06% and Sadhana Nitro trailing at -88.23%.

Peers: The peers of ARCL Organics are Alufluoride, Kesar Petroprod., Hind.Organ.Chem., Sadhana Nitro, Oriental Carbon, IVP, Kanchi Karpooram, ZRZ Bioenergy, and Polychem.<BR><BR>Quality Snapshot: Excellent management risk is observed at Alufluoride, while Average management risk is found at Kesar Petroprod., Sadhana Nitro, Oriental Carbon, IVP, Kanchi Karpooram, and Polychem, and the rest. Below Average management risk is present at Hind.Organ.Chem., ZRZ Bioenergy, and Archit Organosys. Growth is Excellent at Alufluoride, Good at Kesar Petroprod. and IVP, Average at Sadhana Nitro, Oriental Carbon, Kanchi Karpooram, and Polychem, and Below Average at Hind.Organ.Chem., ZRZ Bioenergy, and Archit Organosys. Capital Structure is Excellent at Oriental Carbon and Kanchi Karpooram, Good at Alufluoride and ARCL Organics, Average at Archit Organosys, and Below Average at Kesar Petroprod., Hind.Organ.Chem., Sadhana Nitro, IVP, ZRZ Bioenergy, and Polychem.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Kesar Petroprod. at 59.06%, while the peer with the lowest is Sadhana Nitro at -88.23%. ARCL Organics has a significantly higher 1-year return of 258.88%. Additionally, the six-month return is negative for Sadhana Nitro, Hind.Organ.Chem., IVP, and Polychem.

Who are in the management team of ARCL Organics?

As of March 2016, the management team of ARCL Organics includes Trinetra Gokarannath Bajpai (Director), Suraj Ratan Mundhra (Chairman), Mukesh Mundhra (Director), Mihir Kumar Ghosh (Director), and Ajay Kumar Minani (Whole-time Director). These individuals are responsible for the company's governance and operations.

As of March 2016, the management team of ARCL Organics includes the following individuals:<BR><BR>1. Trinetra Gokarannath Bajpai - Director<BR>2. Suraj Ratan Mundhra - Chairman<BR>3. Mukesh Mundhra - Director<BR>4. Mihir Kumar Ghosh - Director<BR>5. Ajay Kumar Minani - Whole-time Director<BR><BR>These members play key roles in the governance and operational oversight of the company.

What does ARCL Organics do?

ARCL Organics Ltd is a micro-cap company in the commodity chemicals industry, incorporated in 1992, with recent quarterly net sales of 722 Cr and net profit of 56 Cr as of March 2025. Key metrics include a P/E ratio of 17.00 and a market cap of INR 203 Cr.

Overview: <BR>ARCL Organics Ltd operates in the commodity chemicals industry and is categorized as a micro-cap company.<BR><BR>History: <BR>The company was incorporated in 1992 and was initially known as Allied Chemical Private Limited. It changed its name to ARCL Organics Private Limited on January 11, 2010, and subsequently became a Public Limited Company on February 08, 2010. The most recent quarterly results reported net sales and net profit for March 2025.<BR><BR>Financial Snapshot: <BR>Net Sales: 722 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 56 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: INR 203 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 17.00 <BR>Industry P/E: 24 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.21 <BR>Return on Equity: 15.93% <BR>Price to Book: 2.68 <BR><BR>Contact Details: <BR>Registrar Address: Not available. <BR>Phone: N/A <BR>Email: N/A <BR>Website: N/A

Who are the top shareholders of the ARCL Organics?

The top shareholders of ARCL Organics are Arc Holdings Ltd with 15.29%, followed by Arcl Organics Ltd (SBICAP Trustee) at 11.28%, and individual investors holding 12.36%. There are no mutual funds or foreign institutional investors currently involved.

The top shareholders of ARCL Organics include Arc Holdings Ltd, which holds the highest promoter stake at 15.29%. Additionally, the highest public shareholder is Arcl Organics Ltd, operated by SBICAP Trustee, with a holding of 11.28%. Individual investors collectively hold 12.36% of the company's shares. Notably, there are no mutual funds or foreign institutional investors (FIIs) currently holding shares in the company.

How big is ARCL Organics?

As of 24th July, ARCL Organics Ltd has a market capitalization of 221.00 Cr, with recent net sales of 250.59 Cr and a net profit of 12.34 Cr over the last four quarters.

As of 24th July, <BR><BR>Market Cap: ARCL Organics Ltd has a market capitalization of 221.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 250.59 Cr, while the sum of Net Profit for the same period is 12.34 Cr.<BR><BR>Balance Sheet Snapshot: For the reporting period of March 2025, Shareholder's Funds are valued at 77.45 Cr, and Total Assets amount to 168.89 Cr.

How has been the historical performance of ARCL Organics?

ARCL Organics has experienced significant growth over the past four years, with net sales increasing from 141.26 Cr in Mar'22 to 250.59 Cr in Mar'25, and profit after tax rising to 12.33 Cr. Despite a slight decline in operating profit margin, the company has improved its earnings per share and total assets, indicating strong financial health.

Answer:<BR>The historical performance of ARCL Organics shows a steady growth in net sales and profitability over the past four years, with net sales increasing from 141.26 Cr in Mar'22 to 250.59 Cr in Mar'25. The total operating income has followed a similar upward trend, reaching 250.59 Cr in Mar'25, up from 141.26 Cr in Mar'22. The company's total expenditure has also risen, from 126.02 Cr in Mar'22 to 226.78 Cr in Mar'25, primarily driven by increased raw material costs, which rose from 107.66 Cr to 178.83 Cr during the same period. Operating profit (PBDIT) has improved from 17.63 Cr in Mar'22 to 26.16 Cr in Mar'25, although the operating profit margin has slightly declined from 10.79% to 9.5%. Profit before tax has shown a consistent increase, reaching 16.75 Cr in Mar'25, while profit after tax has also grown to 12.33 Cr from 10.53 Cr in Mar'22. The earnings per share have increased from 13.16 in Mar'22 to 15.41 in Mar'25, reflecting the company's profitability growth. On the balance sheet, total assets have increased from 97.89 Cr in Mar'22 to 168.89 Cr in Mar'25, with total liabilities also rising from 97.89 Cr to 168.89 Cr. The book value per share has improved significantly from 53.18 in Mar'22 to 96.81 in Mar'25. Cash flow from operating activities has shown variability, with a cash flow of 5.00 Cr in Mar'25 compared to 1.00 Cr in Mar'22.<BR><BR>Breakdown:<BR>ARCL Organics has demonstrated significant growth in its financial performance over the past four years. Net sales surged from 141.26 Cr in Mar'22 to 250.59 Cr in Mar'25, while total operating income mirrored this growth, reaching 250.59 Cr. Despite rising total expenditure, which increased to 226.78 Cr in Mar'25, the company managed to enhance its operating profit to 26.16 Cr, although the operating profit margin slightly decreased to 9.5%. Profit before tax rose to 16.75 Cr, and profit after tax reached 12.33 Cr, indicating a solid profitability trend. The earnings per share also improved, reflecting the company's financial health. On the balance sheet, total assets and liabilities both increased to 168.89 Cr, and the book value per share rose significantly, showcasing enhanced shareholder value. Cash flow from operating activities was 5.00 Cr in Mar'25, indicating a positive cash generation despite fluctuations in working capital. Overall, ARCL Organics has shown a robust growth trajectory in both revenue and profitability metrics.

When is the next results date for ARCL Organics Ltd?

The next results date for ARCL Organics Ltd is 11 February 2026.

The next results date for ARCL Organics Ltd is scheduled for 11 February 2026.

Are ARCL Organics Ltd latest results good or bad?

ARCL Organics Ltd's latest Q3 FY26 results are concerning, showing a net profit loss of -₹8.81 crores, a significant decline in sales, and an operating margin of -0.60%. The stock has dropped 34.30% year-to-date, leading to a "SELL" rating due to serious operational and financial challenges.

ARCL Organics Ltd's latest results for Q3 FY26 are quite concerning. The company reported a net profit of -₹8.81 crores, which marks a dramatic decline of 222.02% quarter-on-quarter and an alarming 592.18% drop year-on-year. This is the first time the company has recorded an operating loss, with an operating margin of -0.60%, a significant fall from 13.25% in the previous quarter.<BR><BR>Net sales also suffered, dropping to ₹53.47 crores, down 37.96% from the previous quarter and 13.70% year-on-year, indicating a severe operational collapse. The company's financial health appears to be under significant stress, as evidenced by the sharp decline in revenue and profit margins.<BR><BR>Moreover, the stock has reacted negatively, trading down 34.30% year-to-date and 42.71% below its 52-week high. The proprietary advisory score has dropped to 35/100, leading to a "SELL" rating, reflecting a dramatic downgrade from its previous "BUY" status.<BR><BR>Overall, the results indicate a troubling trend for ARCL Organics, raising serious questions about its operational stability and future prospects.

Should I buy, sell or hold ARCL Organics Ltd?

Why is ARCL Organics Ltd falling/rising?

As of 16-Mar, ARCL Organics Ltd's stock price is declining, currently at Rs 164.05, reflecting a -4.37% change and hitting a new 52-week low. The stock has significantly underperformed against the Sensex across various time frames, with a year-to-date decline of -56.72%, driven by poor financial results and waning investor interest.

As of 16-Mar, ARCL Organics Ltd is experiencing a decline in its stock price, currently at Rs 164.05, which reflects a change of -7.5 (-4.37%). The stock has been on a downward trend, having fallen consecutively for the last three days, resulting in a total decline of -9.11% during this period. Today, the stock hit a new 52-week low of Rs 163, indicating significant selling pressure.<BR><BR>The stock's performance over various time frames shows a stark underperformance compared to the benchmark Sensex. Over the past week, ARCL Organics has decreased by -9.16%, while the Sensex has only fallen by -2.66%. In the last month, the stock has plummeted by -20.90%, compared to the Sensex's -9.34%. Year-to-date, the stock has seen a staggering decline of -56.72%, while the Sensex has only decreased by -11.40%. This trend of underperformance extends to the past year, where ARCL Organics has lost -33.72% compared to a modest gain of +2.27% for the Sensex.<BR><BR>Factors contributing to this decline include poor financial performance, with the company's net sales reported at their lowest at Rs 53.47 crore and a significant drop in profit after tax (PAT) of -277.6% compared to the previous four-quarter average. Additionally, the stock is trading below its moving averages across various time frames, indicating a bearish trend. The sector itself, fertilizers, has also seen a decline of -2.67%, further impacting ARCL Organics' performance.<BR><BR>Investor participation appears to be waning, as evidenced by a 63.49% drop in delivery volume compared to the five-day average. This lack of interest from investors, combined with the company's poor long-term growth prospects and below-par performance in both the near and long term, reinforces the downward trajectory of the stock price.

Which are the latest news on ARCL Organics?

Which are the latest news on ARCL Organics?

Which are the latest news on ARCL Organics?